Authors: McLeod, D Zinner, N Tomera, K Gleason, D Fotheringham, N Campion, M Garnick, MB

Citation: D. Mcleod et al., A phase 3, multicenter, open-label, randomized study of abarelix versus leuprolide acetate in men with prostate cancer, UROLOGY, 58(5), 2001, pp. 756-761

Authors: Lightner, D Calvosa, C Andersen, R Klimberg, I Brito, CG Snyder, J Gleason, D Killion, D MacDonald, J Khan, AU Diokno, A Sirls, LT Saltzstein, D

Citation: D. Lightner et al., A new injectable bulking agent for treatment of stress urinary incontinence: Results of a multicenter, randomized, controlled, double-blind study of durasphere, UROLOGY, 58(1), 2001, pp. 12-15

Authors: Tomera, K Gleason, D Gittelman, M Moseley, W Zinner, N Murdoch, M Menon, M Campion, M Garnick, MB

Citation: K. Tomera et al., The gonadotropin-releasing hormone antagonist abarelix depot versus luteinizing hormone releasing hormone agonists leuprolide or goserelin: Initial results of endocrinological and biochemical efficacies in patients with prostate cancer, J UROL, 165(5), 2001, pp. 1585-1589

Authors: Brubaker, L Harris, T Gleason, D Newman, D North, B

Citation: L. Brubaker et al., The external urethral barrier for stress incontinence: A multicenter trialof safety and efficacy, OBSTET GYN, 93(6), 1999, pp. 932-937